BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26228109)

  • 1. Prognostic Impact of Peritumoral IL-17-Positive Cells and IL-17 Axis in Patients with Intrahepatic Cholangiocarcinoma.
    Asukai K; Kawamoto K; Eguchi H; Konno M; Nishida N; Koseki J; Noguchi K; Hasegawa S; Ogawa H; Yamada D; Tomimaru Y; Tomokuni A; Asaoka T; Noda T; Wada H; Gotoh K; Marubashi S; Nagano H; Doki Y; Mori M; Ishii H
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1524-31. PubMed ID: 26228109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of interleukin-35 in intrahepatic cholangiocarcinoma is a prognostic indicator after curative resection.
    Zhang MX; Gan W; Jing CY; Zheng SS; Zhang J; Shen HJ; Xu X; Lin JJ; Zhang BH; Qiu SJ
    Cancer Sci; 2018 Apr; 109(4):1195-1206. PubMed ID: 29446854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Impact of Leucine-Rich α-2-Glycoprotein-1 in Cholangiocarcinoma and Its Association With the IL-6/TGF-β1 Axis.
    Jin Z; Kobayashi S; Gotoh K; Takahashi T; Eguchi H; Naka T; Mori M; Doki Y
    J Surg Res; 2020 Aug; 252():147-155. PubMed ID: 32278969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study.
    Zhao Q; Yu WL; Lu XY; Dong H; Gu YJ; Sheng X; Cong WM; Wu MC
    Chin J Cancer; 2016 Aug; 35(1):82. PubMed ID: 27552844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and Prognosis.
    Chen Y; Hong Z; Lu S; Zhang N; Rong G; Chang X; Liu Z; Bai W; Dong Z; Gao X; Zeng Z; Lu Y
    Med Sci Monit; 2018 Nov; 24():7875-7882. PubMed ID: 30390420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection.
    Jing CY; Fu YP; Shen HJ; Zheng SS; Lin JJ; Yi Y; Huang JL; Xu X; Zhang J; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
    Oncotarget; 2017 Feb; 8(8):13293-13303. PubMed ID: 28076328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition.
    Lv B; Ma L; Tang W; Huang P; Yang B; Wang L; Chen S; Gao Q; Zhang S; Xia J
    Cell Physiol Biochem; 2018; 48(1):158-172. PubMed ID: 30001540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
    Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
    Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection.
    Spolverato G; Kim Y; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Clark Gamblin T; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Tran TB; Wallis Marsh J; Pawlik TM
    Ann Surg Oncol; 2016 Jan; 23(1):235-43. PubMed ID: 26059651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Program Death 1 Immune Checkpoint and Tumor Microenvironment: Implications for Patients With Intrahepatic Cholangiocarcinoma.
    Gani F; Nagarajan N; Kim Y; Zhu Q; Luan L; Bhaijjee F; Anders RA; Pawlik TM
    Ann Surg Oncol; 2016 Aug; 23(8):2610-7. PubMed ID: 27012989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?
    Hakeem AR; Marangoni G; Chapman SJ; Young RS; Nair A; Hidalgo EL; Toogood GJ; Wyatt JI; Lodge PA; Prasad KR
    Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1047-54. PubMed ID: 25051217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlation of cadherin-17 marker with advanced tumor stages and poor prognosis of cholangiocarcinoma.
    Zheng BH; Shen S; Wong KF; Gong ZJ; Sun WT; Ni XJ; Wang JW; Hu MY; Liu H; Ni XL; Liu HB; Luk JM; Suo T
    J Surg Oncol; 2021 Apr; 123(5):1253-1262. PubMed ID: 33524213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expressions of HMGA2 and Thy1 in extrahepatic cholangiocarcinoma and their clinicopathological significances.
    Liu R; Yang Z; Huang S; Li D; Zou Q; Yuan Y
    Surg Oncol; 2019 Jun; 29():41-47. PubMed ID: 31196492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbohydrate Antigen 19-9 Is a Prognostic Factor Which Correlates With HDAC1 and HIF-1α for Intrahepatic Cholangiocarcinoma.
    Ohta S; Morine Y; Imura S; Ikemoto T; Arakawa Y; Iwahashi S; Saito YU; Yamada S; Wada Y; Yamashita S; Bando Y; Shimada M
    Anticancer Res; 2019 Nov; 39(11):6025-6033. PubMed ID: 31704828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma.
    Buettner S; Galjart B; van Vugt JLA; Bagante F; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Margonis GA; Weiss M; Bauer TW; Shen F; Poultsides GA; Marsh JW; IJzermans JNM; Groot Koerkamp B; Pawlik TM
    J Surg Oncol; 2017 Dec; 116(8):1085-1095. PubMed ID: 28703880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CK7/CK19 index: A potential prognostic factor for postoperative intrahepatic cholangiocarcinoma patients.
    Liu LZ; Yang LX; Zheng BH; Dong PP; Liu XY; Wang ZC; Zhou J; Fan J; Wang XY; Gao Q
    J Surg Oncol; 2018 Jun; 117(7):1531-1539. PubMed ID: 29513894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between microvessel count and postoperative survival in patients with intrahepatic cholangiocarcinoma.
    Nanashima A; Shibata K; Nakayama T; Tobinaga S; Araki M; Kunizaki M; Takeshita H; Hidaka S; Sawai T; Nagayasu T; Tagawa T
    Ann Surg Oncol; 2009 Aug; 16(8):2123-9. PubMed ID: 19434454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.